19.16 USD
↗ 0.41 (2.16%)LIVE (AS OF 10:32 AM EST)
Shares of Acadia Pharmaceuticals Inc. (ACAD) are trading at $19.16. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (26.1%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place ACAD at a fair price relative to peers.
Technical & fundamental data as of Nov 13, 2026.